Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Interstitial Colloidal 32P for Locally Recurrent Prostate Cancer Failing Radiation

NCT00005939 is registered in ClinicalTrials.gov with Center for Molecular Medicine as lead sponsor.

NCT NCT00005939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Interstitial Colloidal 32P for Locally Recurrent Prostate Cancer Failing Radiation
Lead sponsor
Center for Molecular Medicine
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 1999
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer